TB and HIV: joint problems, joint solutions?
Elzinga
Gijs
G
Global Working Group on TB/HIV, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
Nunn
Paul
P
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D023241:Antiretroviral Therapy, Highly Active; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003140:Communicable Disease Control / Q000458:organization & administration*; D003191:Comprehensive Health Care / Q000458:organization & administration*; D023801:Directly Observed Therapy; D014943:Global Health; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D015528:HIV Seroprevalence; D006801:Humans; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D014944:World Health Organization
D000995:Antitubercular Agents